Author: Brad Thomas, Wide Moat Research

It’s currently trading at a rare 11% discount from its historical average over the past decade… and with the rollout of AI across its entire business, the discount may not last long.

You know this company… but may not fully appreciate its full potential for your portfolio.

The company’s earnings will get a strong boost from rising insurance premiums and high interest rates in the years to come.

Now is the time to consider buying: shares are extremely cheap and its sector is just starting to turn a corner.

If you want to capitalize on the drugstore meltdown, now is your chance while shares are down.